GlaxoSmithKline

Most recent

• Marks & Spencer lifted by food sales, while Debenhams beats forecasts

  10 Jan 2012: Marks reported food sales up 3% but general merchandise disappoints, as FTSE regains ground helped by miners

• FTSE falters again, as Glaxo reveals mixed drug trial results and AstraZeneca sends out wrong data

  9 Jan 2012: GlaxoSmithKline presses ahead with regulatory approval for lung drug Relovair, while Astra confirms guidance after error

• GlaxoSmithKline drops on drug trial results, while AstraZeneca gives City wrong data

  9 Jan 2012: GlaxoSmithKline files for regulatory approval of lung drug, but analysts note concerns about the treatment

• ITV gains but BSkyB loses after analyst report, while FTSE ends up on week

  6 Jan 2012: Morgan Stanley raises recommendation on ITV but warns of problems ahead for satellite broadcaster

• New Year honours include an award for tycoon jailed over stock market scandal

  31 Dec 2011: Business gongs include CBE for Gerald Ronson, one of the 'Guinness four', for charity work since serving jail term in 1990

• FTSE 100 gains ground, while Burberry moves higher on French venture move

  20 Dec 2011: Markets shake off eurozone worries in light trading, while luxury goods group says it may renegotiate contract with Interparfums

• AstraZeneca drops 2.5% after drug failures and write-off, but FTSE struggles for direction

  20 Dec 2011: AstraZeneca says two drugs did badly in clinical trials, while leading shares uncertain as eurozone crisis continues

• Imperial Tobacco in demand as FTSE 100 slips back on eurozone woes

  12 Dec 2011: Cigarette companies wanted for defensive qualities, but investors still nervous after EU summit

• Market reaction muted as UK exits European bailout talks

  9 Dec 2011: The markets reacted steadily to news of the UK's exit from Eurozone plans, with the FTSE relatively flat at -0.07% to 5479 points.

• FTSE falls 1% as nervousness grows ahead of EU summit

  8 Dec 2011: Insurers come under pressure, with Aviva downgraded by Exane

• Cairn aims to return $3.5bn to shareholders, while FTSE awaits banks decisions and summit

  8 Dec 2011: Cairn Energy plans to give back cash after long-awaited completion of Indian deal with Vedanta Resources

• FTSE wavers ahead of EU summit but retailers routed on fears of poor Christmas

  6 Dec 2011: Survey shows big falls in non-food items, hitting clothing and electrical shares

• Wolseley builds up 2% rise despite US asbestos problem, as FTSE drifts lower

  6 Dec 2011: Building materials group reports 16% profit rise helped by strong US growth, but warns of mislabelled products

• Miners under pressure on downturn worries, as FTSE 100 falls back again

  30 Nov 2011: Eurozone crisis continues to unsettle investors, while banks fall after Standard and Poor's downgrade

• Sir James Dyson funds £1.4m professorship at Cambridge University

  24 Nov 2011:

  Sir James Dyson has committed £1.4m over ten years to fund a Cambridge professorship in fluid mechanics – the scientific discipline behind his vacuum cleaner and airblade hand dryer

• Next
• 1
• 2
• 3
• 4
• 5

1-15 of 505 for GlaxoSmithKline